Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 AUD | -2.56% |
|
+26.67% | +117.14% |
05-29 | Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks | MT |
04-11 | Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+117.14% | 33.14M | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
+21.21% | 2.1B | |
-9.38% | 1.76B |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials